Page last updated: 2024-10-24

celecoxib and Muscular Dystrophy, Duchenne

celecoxib has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research Excerpts

ExcerptRelevanceReference
"Celecoxib treatment also induced increases in utrophin A expression ranging from ∼1."1.48Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression. ( Adam, NJ; Jasmin, BJ; Péladeau, C, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Péladeau, C1
Adam, NJ1
Jasmin, BJ1

Other Studies

1 other study available for celecoxib and Muscular Dystrophy, Duchenne

ArticleYear
Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:9

    Topics: Animals; Celecoxib; Cyclooxygenase 2; Diaphragm; Dystrophin; Mice; Mice, Inbred C57BL; Mice, Inbred

2018